`
`SEAGEN INC.,
`
`
`
`
`v.
`
`Plaintiff,
`
`
`DAIICHI SANKYO CO., LTD.,
`
`
`Defendant, and
`
`
`
`
`
`
`
`CASE NO. 2:20-cv-00337-JRG
`
`
`IN THE UNITED STATES DISTRICT COURT
`EASTERN DISTRICT OF TEXAS
`MARSHALL DIVISION
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`
`ASTRAZENECA PHARMACEUTICALS
`LP and ASTRAZENECA UK LTD.,
`
`
`Intervenor-Defendants.
`
`
`
`
`
`
`DEFENDANTS’ UNOPPOSED MOTION FOR EXPEDITED
`BRIEFING ON ITS MOTION TO STAY PENDING POST-GRANT REVIEW
`
`In accordance with Local Rule CV-7(e), Defendants Daiichi Sankyo Company, Limited,
`
`AstraZeneca Pharmaceuticals LP, and AstraZeneca UK Ltd. (collectively, “Defendants”) move
`
`for expedited briefing on its Motion to Stay Pending Post-Grant Review (Dkt. No. 392). To
`
`facilitate the Court’s simultaneous review of the Parties’ respective outstanding motions (see also
`
`Dkt. No. 390), Defendants respectfully request that the Court order Plaintiff Seagen Inc.
`
`(“Seagen”) to respond to Defendants’ Motion to Stay Pending Post-Grant Review (Dkt. No. 392)
`
`on or before May 4, 2022. Seagen does not oppose this motion.
`
`
`
`
`
`Case 2:20-cv-00337-JRG Document 394 Filed 04/27/22 Page 2 of 4 PageID #: 15453
`
`
`Dated: April 27, 2022
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`
`
` /s/ Preston K. Ratliff II
`Deron R. Dacus
`Texas State Bar No. 00790553
`ddacus@dacusfirm.com
`THE DACUS FIRM, P.C.
`821 ESE Loop 323, Suite 430
`Tyler, Texas 75701
`Telephone: 903.705.1117
`Facsimile: 903.581.2543
`
`J. Mark Mann
`Texas State Bar No. 12926150
`mark@themannfirm.com
`G. Blake Thompson
`Texas State Bar No. 240420033
`blake@themannfirm.com
`MANN | TINDEL | THOMPSON
`201 E. Howard Street
`Henderson, Texas
`Telephone: 903.357.8540
`Facsimile: 903.657.6003
`
`Attorneys for Defendant Daiichi Sankyo
`Company, Limited
`
`OF COUNSEL:
`
`Preston K. Ratliff II
`Ashley N. Mays-Williams
`PAUL HASTINGS LLP
`200 Park Avenue
`New York, New York 10166
`Telephone: 212.318.6000
`
`Jeffrey A. Pade
`PAUL HASTINGS LLP
`2050 M Street NW
`Washington, DC 20036
`Telephone: 202.551.1700
`
`Attorneys for Defendant Daiichi Sankyo
`Company, Limited
`
`
`
`- 2 -
`
`
`
`Case 2:20-cv-00337-JRG Document 394 Filed 04/27/22 Page 3 of 4 PageID #: 15454
`
`
`
`/s/ Thomas S. Fletcher
`Jennifer Parker Ainsworth
`Texas State Bar No. 00784720
`WILSON, ROBERTSON
`& CORNELIUS, P.C.
`909 ESE Loop 323, Suite 400
`Tyler, Texas 75701
`Phone: (903) 509-5000
`Facsimile: (903) 509-5092
`
`Attorney for Intervenor-Defendants
`AstraZeneca Pharmaceuticals LP and
`AstraZeneca UK Ltd.
`
`OF COUNSEL:
`
`David I. Berl
`Thomas S. Fletcher
`Jessamyn Berniker
`Jessica L. Pahl
`Kathryn Kayali
`Kevin Hoagland-Hanson
`Angela X. Gao
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`Phone: (202) 434-5000
`Facsimile: (202) 434-5029
`
`Attorneys for Intervenor-Defendants
`AstraZeneca Pharmaceuticals LP and
`AstraZeneca UK Ltd.
`
`
`
`
`
`- 3 -
`
`
`
`
`
`Case 2:20-cv-00337-JRG Document 394 Filed 04/27/22 Page 4 of 4 PageID #: 15455
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that a copy of the foregoing document was filed electronically in
`
`compliance with Local Rule CV-5(a). Therefore, this document was served on all counsel who are
`
`deemed to have consented to electronic service on this the 27 day of April, 2022.
`
`
`
`
`
`
`
`
`
`
`/s/ Preston K. Ratliff II
`
`
`
`
`CERTIFICATE OF CONFERENCE
`
`I hereby certify that the Parties have met and conferred via email regarding this Motion on
`
`April 27, 2022. This Motion is unopposed.
`
`
`
`
`
`
`
`
`
`
`
`/s/ Preston K. Ratliff II
`
`
`
`
`
`
`